Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $24.42 in the prior trading day, ArriVent BioPharma Inc (NASDAQ: AVBP) closed at $23.64, down -3.19%. In other words, the price has decreased by -$3.19 from its previous closing price. On the day, 0.53 million shares were traded. AVBP stock price reached its highest trading level at $25.4999 during the session, while it also had its lowest trading level at $22.9.
Ratios:
Our goal is to gain a better understanding of AVBP by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.90 and its Current Ratio is at 14.90. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, BTIG Research on December 10, 2025, initiated with a Buy rating and assigned the stock a target price of $45.
On November 25, 2025, Truist started tracking the stock assigning a Buy rating and target price of $43.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVBP now has a Market Capitalization of 975891328 and an Enterprise Value of 675681344.
Stock Price History:
The Beta on a monthly basis for AVBP is 0.89, which has changed by -0.09286773 over the last 52 weeks, in comparison to a change of 0.12838376 over the same period for the S&P500. Over the past 52 weeks, AVBP has reached a high of $29.71, while it has fallen to a 52-week low of $15.47. The 50-Day Moving Average of the stock is 14.14%, while the 200-Day Moving Average is calculated to be 16.19%.
Shares Statistics:
The stock has traded on average 347.91K shares per day over the past 3-months and 453570 shares per day over the last 10 days, according to various share statistics. A total of 40.85M shares are outstanding, with a floating share count of 26.30M. Insiders hold about 36.30% of the company’s shares, while institutions hold 70.51% stake in the company. Shares short for AVBP as of 1764288000 were 7262061 with a Short Ratio of 20.87, compared to 1761868800 on 6927026. Therefore, it implies a Short% of Shares Outstanding of 7262061 and a Short% of Float of 23.380000000000003.
Earnings Estimates
The dynamic stock of ArriVent BioPharma Inc (AVBP) is currently being evaluated by a team of 10.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.95, with high estimates of -$0.87 and low estimates of -$1.05.
Analysts are recommending an EPS of between -$2.96 and -$4.82 for the fiscal current year, implying an average EPS of -$4.28. EPS for the following year is -$3.99, with 10.0 analysts recommending between -$3.25 and -$5.25.
